ImmBio approach is to select from within the breadth of opportunities where the technology platforms have strong utility, to focus on specific products. As progress is made and proof of principle established, the portfolio will be extended.

ImmBio intends to take products no further than early clinical, with licensees progressing products through to commercialisation.